Followers | 240 |
Posts | 12051 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |
Thursday, May 10, 2012 10:56:44 PM
Seems to be the primary buyer of shares, too.
Listed below are trades for the last 60 days.
Trade Date/Buy or Sale/Number of Shares/Price
4/27/2012 Buy 400 $1.925
4/25/2012 Buy 2,866 $1.92
4/9/2012 Buy 1,000 $1.92
4/5/2012 Buy 22,400 $1.9298
4/2/2012 Buy 200 $1.9
3/30/2012 Buy 10,000 $1.85
3/29/2012 Buy 10,000 $1.83
3/28/2012 Buy 19,400 $1.8252
3/22/2012 Buy 1,300 $1.85
3/21/2012 Buy 1,213 $1.85
3/20/2012 Buy 18,020 $1.85
3/19/2012 Buy 1,352 $1.85
3/9/2012 Buy 2,200 $1.87
3/8/2012 Buy 8,361 $1.87
3/7/2012 Buy 1,639 $1.87
3/6/2012 Buy 15,744 $1.8877
3/5/2012 Buy 4,256 $1.8986
3/2/2012 Buy 10,244 $1.883
http://sec.gov/Archives/edgar/data/9235/000092627412000005/bkfqual-13da4.txt
[Time to update spreadsheet again]
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=75092072
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM